Scientists who want a say in the future of their inventions are once again moving from academia to the C-suite ...

Argonne National Laboratory, Flagship Pioneering, Terray, Weights & Biases and Dozens More Organizations Among Contributors ...

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

The company has submitted an Investigational New Drug application for a promising treatment targeting ... The collaboration with Genentech to develop genomic medicines for neurodegenerative diseases ...

Continuous research has led to new drug developments, particularly disease-modifying ... Key multiple sclerosis companies such as Mapi Pharma, Novartis, Immunic, Biocad, Apimeds, Genentech (Roche), AB ...

Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...

SALMONELLA is normally associated with violent food poisoning. But now scientists believe the horror bug could be manipulated ...

Like most of its peers in the biopharma sector, Genentech has been working on AI-powered technologies for drug discovery and development, coming up with a proprietary set of algorithms and other ...

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

Stephen Abreu has been appointed by the Board as Executive Director. He will lead the organization's overall strategy and ...

Roche’s Genentech unit signed a trio of deals this week to add new drug discovery platforms to its repertoire. The three drug discovery deals are with Convelo Therapeutics in neurological ...